pentobarbital will lower the extent or outcome of linagliptin by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Use of other treatment plans is strongly suggested when linagliptin is always to be administered having a CYP3A4 inducer pentobarbital will minimize the l